Advancing the Use of Complex Innovative Designs in Clinical Trials: From Pilot to Practice - Part 2

U.S. Food and Drug Administration
U.S. Food and Drug Administration
921 بار بازدید - 6 روز پیش - On March 5, 2024, FDA
On March 5, 2024, FDA is conducted a public workshop to discuss aspects of complex adaptive, Bayesian, and other novel clinical trial designs. The purpose of this public workshop is to facilitate discussion on the use of external data sources, Bayesian statistical methods, and simulations in complex innovative trial designs as well as trial implementation.
6 روز پیش در تاریخ 1403/06/23 منتشر شده است.
921 بـار بازدید شده
... بیشتر